AB Corporate Bond ETF (NASDAQ:EYEG) Sees Significant Drop in Short Interest

AB Corporate Bond ETF (NASDAQ:EYEG) was the target of a significant drop in short interest during the month of April. As of April 30th, there was short interest totaling 250 shares, a drop of 54.5% from the April 15th total of 549 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 99 shares, the short-interest ratio is presently 2.5 days.

Institutional Trading of AB Corporate Bond ETF

Several institutional investors have recently added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC lifted its stake in AB Corporate Bond ETF by 32.5% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 157,702 shares of the specialty pharmaceutical company’s stock worth $5,634,000 after purchasing an additional 38,685 shares during the last quarter. Jane Street Group LLC increased its position in shares of AB Corporate Bond ETF by 166.7% during the fourth quarter. Jane Street Group LLC now owns 15,741 shares of the specialty pharmaceutical company’s stock worth $563,000 after acquiring an additional 9,839 shares during the period. Finally, Kestra Advisory Services LLC purchased a new position in shares of AB Corporate Bond ETF during the fourth quarter worth approximately $34,000. Institutional investors own 64.16% of the company’s stock.

AB Corporate Bond ETF Trading Down 0.5%

NASDAQ EYEG traded down $0.18 during trading on Friday, hitting $35.01. The stock had a trading volume of 13 shares, compared to its average volume of 193. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.07 and a current ratio of 3.07. The stock has a market capitalization of $28.01 million, a price-to-earnings ratio of -20.84 and a beta of 0.18. AB Corporate Bond ETF has a one year low of $34.59 and a one year high of $36.63. The stock has a 50 day simple moving average of $35.32 and a 200 day simple moving average of $35.72.

AB Corporate Bond ETF Announces Dividend

The company also recently disclosed a monthly dividend, which was paid on Wednesday, May 6th. Shareholders of record on Friday, May 1st were paid a $0.1404 dividend. The ex-dividend date of this dividend was Friday, May 1st. This represents a c) annualized dividend and a yield of 4.8%. AB Corporate Bond ETF’s dividend payout ratio (DPR) is presently -103.57%.

About AB Corporate Bond ETF

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.